Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

28.07
+0.28001.01%
Post-market: 28.080.0100+0.04%19:59 EDT
Volume:37.11M
Turnover:1.04B
Market Cap:159.60B
PE:36.94
High:28.43
Open:27.77
Low:27.66
Close:27.79
52wk High:28.75
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:1.05
T/O Rate:0.66%
Dividend:1.72
Dividend Rate:6.13%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.87
PE(LYR):20.57

Loading ...

Pfizer Stock Near Lows But Analysts See Upside Ahead

TIPRANKS
·
Jul 18

Pfizer (PFE) Could Be 16% Undervalued On New FDA Approval In Bladder Cancer

Simply Wall St.
·
Jul 17

Exclusive: Pfizer Temporarily Discontinues Premarin Vaginal Cream in India, Citing Supply Challenges

THOMSON REUTERS
·
Jul 17

Arbutus Biopharma, Genevant sue Pfizer, BioNTech Over Lipid Nanoparticle Patents

MT Newswires Live
·
Jul 16

Arbutus Files Patent Infringement Suits Against Pfizer, Biontech over LNP Technology

Reuters
·
Jul 16

Arbutus Biopharma Corp - Co and Genevant File Lawsuit in Canada Seeking Injunction and Damages Against Pfizer/biontech

THOMSON REUTERS
·
Jul 16

Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV) and Pfizer (PFE)

TIPRANKS
·
Jul 16

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 16

Sanofi Sues Pfizer, Moderna over COVID Shot Technology

Reuters
·
Jul 15

Pfizer call volume above normal and directionally bullish

TIPRANKS
·
Jul 15

3 Stocks I Will Be Avoiding

The Smart Investor
·
Jul 15

New York City Officials Inspecting Other Buildings After Midtown High Rise Buckled

Dow Jones
·
Jul 15

Cboe data shows mixed options sentiment in Pfizer with shares down 0.88%

TIPRANKS
·
Jul 15

Law Firm Quinn Emanuel Barred from Antitrust Case over Client Conflict

Reuters
·
Jul 15

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 14

Moderately bullish activity in Pfizer with shares up 1.1%

TIPRANKS
·
Jul 14

Pfizer is Maintained at Buy by Guggenheim

Dow Jones
·
Jul 13

BMO Capital Adjusts Price Target on Pfizer to $30 From $34, Maintains Outperform Rating

MT Newswires Live
·
Jul 13

Pfizer, Astellas Secure FDA Nod For Bladder Cancer Drug

MT Newswires Live
·
Jul 13

Pfizer (PFE) Wins FDA Approval For First Platinum Free Bladder Cancer Regimen

Simply Wall St.
·
Jul 12